Paediatric Behcet's disease with sinus venous thrombosis: experience from three centres in Turkey

被引:1
|
作者
Demir, S. [1 ]
Acari, C. [2 ]
Basaran, O. [3 ]
Sag, E. [1 ]
Oguz, K. Karli [4 ]
Bilginer, Y. [1 ]
Unsal, S. E. [2 ]
Ozen, S. [1 ]
机构
[1] Hacettepe Univ, Fac Med, Div Rheumatol, Dept Paediat, TR-06100 Ankara, Turkey
[2] Dokuz Eylul Univ, Fac Med, Dept Paediat, Div Rheumatol, Izmir, Turkey
[3] Univ Hlth Sci, Ankara Child Hlth & Dis Haematol Oncol Training &, Paediat Rheumatol, Ankara, Turkey
[4] Hacettepe Univ, Dept Radiol, Fac Med, Ankara, Turkey
关键词
Behcet's disease; non parenchymal Behcet's disease; cerebral venous sinus thrombosis; vasculitis; children; DAGGER-ETS DISEASE; CLINICAL CHARACTERISTICS; PSEUDOTUMOR CEREBRI; ONSET; AZATHIOPRINE; CHILDHOOD; FEATURES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To report our experiences of the juvenile Behcet's disease (BD) patients with cerebral venous sinus thrombosis (CVST) and to review previous studies reporting the clinical characteristics and outcomes of juvenile BD with CVST. Methods. Clinical characteristics and outcomes of paediatric patients with CVST who met the Paediatric Behcet's Disease (PEDBD) classification criteria for juvenile BD from 3 referral centres in Turkey were reviewed retrospectively. A systematic review of literature of all published data was conducted. Results. The study group consisted of 12 juvenile BD patients with CVST. At the time of CVST diagnosis, the most common symptom was headache (100%), followed by vomiting (25%), blurred vision (16.7%), and disturbances in eye movements (16.7%). Six (50%) patients presented with CVST. Transverse sinus was the most frequently affected sinus (9/12, 75%) followed by superior sagittal sinus. The mean (+/- 2SD) BDCAF at the CVST diagnosis was 6 (+/- 3.8). Four children (33.3%) had another venous thrombosis apart from CVST. All patients received pulse methylprednisolone for three consecutive days continued with oral prednisolone. Steroid treatment was tapered and discontinued minimum in six months. Eleven patients received azathioprine concomitant to steroid treatment at the time of CVST. All the patients received anticoagulant therapy concomitantly. Only one patient who did not receive azathioprine relapsed. Median follow-up period was 4 years (IQR: 2-5.4). In the literature review, we identified nine articles, describing 35 paediatric CVST patients associated with BD. Thirty patients achieved remission, while five patients had residual neurologic deficit. Conclusion. Neuroimaging is very important in the diagnosis of NBD. We suggest that treatment with immunosuppressants and steroid treatment is essential to decrease the adverse events of corticosteroids in the paediatric population and decrease relapses. Further multicentre studies with prospective follow-up may guide us in better management of these patients.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 50 条
  • [41] Arteriovenous Fistula and cerebral venous thrombosis as a manifestation of Behcet's disease
    Borrego, S.
    Falgas, N.
    Sanchez, A.
    Villas, M.
    Espinosa, G.
    Cervera, A.
    REVISTA DE NEUROLOGIA, 2014, 59 (09) : 424 - 424
  • [42] Characteristics of deep venous thrombosis in Tunisian Behcet's disease patients
    Bellakhal, Syrine
    Said, Fatma
    Ben Salem, Thouraya
    Hamzaoui, Amira
    Braham-Sfaxi, Amel
    Smiti-Khanfir, Monia
    Ben Ghorbel, Imed
    Lamloum, Mounir
    Houman, Mohamed-Habib
    THROMBOSIS RESEARCH, 2012, 130 : S152 - S152
  • [43] Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet's disease
    Feki, M
    Houman, H
    Ghannouchi, M
    Smiti-Khanfir, M
    Hamzaoui, K
    El Matri, L
    Mebazaa, A
    Kaabachi, N
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (12) : 1417 - 1423
  • [44] Comment on "cerebral venous thrombosis in Behcet's disease: a systematic review"
    Borhani-Haghighi, Afshin
    Safari, Anahid
    JOURNAL OF NEUROLOGY, 2011, 258 (05) : 910 - 911
  • [45] VENA CAVA THROMBOSIS CAUSED BY VENOUS INFLAMMATION IN BEHCET'S DISEASE
    Aponte, C. J.
    Arshad, S.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S79 - S79
  • [46] Venous thrombosis and relapses in patients with Behcet's disease. Descriptive analysis from Spanish network of Behcet's disease (REGEB cohort)
    Rodriguez-Carballeira, M.
    Solans, R.
    Larranaga, J. R.
    Garcia-Hernandez, F. J.
    Rios-Fernandez, R.
    Nieto, J.
    Solanich, X.
    Martinez-Valle, F.
    Fonseca, E.
    Munoz, F. J.
    Fraile, G.
    de Escalante, B.
    Boldova, R.
    Hurtado, R.
    Espinosa, G.
    Luis Callejas, Jose
    Garcia Hernandez, F.
    de Escalante, Begona
    Lopez Garrido, Santiago
    Vidaller, Antonio
    Gomez de la Torre, Ricardo
    Teresa Herranz, Maria
    Todoli, Jose
    Jose Munoz-Rodriguez, Francisco
    Fanlo, Patricia
    Garcia-Sanchez, Isabel
    Trapiella, Luis
    Fonseca, Eva
    de Miguel, Borja
    Domingo, Sara
    Vilaplana, Rafael
    Cusacovich, Ivan
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S40 - S44
  • [47] Neutrophil extracellular traps in superficial venous thrombosis of Behcet's disease
    Kawakami, T.
    Yokoyama, K.
    Ikeda, T.
    Nishibata, Y.
    Masuda, S.
    Tomaru, U.
    Ishizu, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S66 - S66
  • [48] Aseptic meningitis, venous sinus thrombosis, intracranial hypertension and callosal involvement contemporaneously in a young patient with Behcet's disease
    Bir, LS
    Sabir, N
    Kilinçer, A
    Çeliker, A
    Erdogan, BS
    SWISS MEDICAL WEEKLY, 2005, 135 (45-46) : 684 - 684
  • [49] Clinical characteristics of cerebral venous thrombosis due to Behcet's disease
    Gungor, L.
    Dogru, H.
    Dogan, B.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 327 - 327
  • [50] Cerebral Sinus Venous Thrombosis and Prothrombotic Risk Factors in Children: A Single-Center Experience From Turkey
    Ozcan, Alper
    Canpolat, Mehmet
    Doganay, Selim
    Unal, Ekrem
    Karakukcu, Musa
    Ozdemir, Mehmet A.
    Patiroglu, Turkan
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (06) : E369 - E372